6/10
08:08 am
glto
Galecto, Inc. (NASDAQ: GLTO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $10.00 to $9.00. They now have an "outperform" rating on the stock.
Medium
Report
Galecto, Inc. (NASDAQ: GLTO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $10.00 to $9.00. They now have an "outperform" rating on the stock.
5/1
04:09 pm
glto
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab [Yahoo! Finance]
Medium
Report
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab [Yahoo! Finance]
5/1
04:01 pm
glto
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
Medium
Report
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab